FREEMAN KEVIN D 4
4 · GALECTIN THERAPEUTICS INC · Filed Apr 9, 2024
Insider Transaction Report
Form 4
FREEMAN KEVIN D
Director
Transactions
- Will/Inheritance
Common Stock
2024-04-09+2,063→ 18,063 total(indirect: By IRA)
Holdings
- 75,000(indirect: By LLC)
Common Stock
- 23,469
Common Stock
Footnotes (1)
- [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.